Skip to main content

Table 3 Risk of NVAF According to the Presence or Absence of Abnormal Glucose Metabolism

From: Association between elevated blood glucose level and non-valvular atrial fibrillation: a report from the Guangzhou heart study

Models for the overall population

Characteristics

Glucose Metabolism

(N = 11,488)

Normal

EBG

T2D

IFG

No. of NVAF/No. of participants

79/8048

65/3440

32/1412

33/2028

Univariable-adjusted model

Referent

1.94 (1.40–2.70) 0.000

2.34 (1.55–3.54) 0.000

1.67 (1.11–2.51) 0.014

Age-adjusted model

Referent

1.44 (1.03–2.02) 0.032

1.65 (1.08–2.51) 0.019

1.29 (0.85–1.95) 0.231

Waist circumference-adjusted model

Referent

1.71 (1.22–2.39) 0.002

2.00 (1.32–3.05) 0.001

1.50 (1.00–2.27) 0.053

BP-adjusted model

Referent

1.65 (1.18–2.31) 0.004

1.94 (1.27–2.96) 0.002

1.44 (0.95–2.18) 0.084

TG-adjusted model

Referent

2.04 (1.46–2.85) 0.000

2.50 (1.64–3.80) 0.000

1.74 (1.15–2.62) 0.009

HDL-adjusted model

Referent

1.92 (1.37–2.67) 0.000

2.29 (1.51–3.48) 0.000

1.66 (1.10–2.49) 0.016

Waist circumference/BP/TG/HDL-adjusted model

Referent

1.60 (1.14–2.25) 0.007

1.87 (1.22–2.87) 0.004

1.41 (0.93–2.14) 0.104

Models for the male population

Characteristics

Glucose Metabolism

(N = 4047)

Normal

EBG

T2D

IFG

No. of NVAF/No. of participants

41/2754

30/1293

14/873

12/754

Univariable-adjusted model

Referent

1.57 (0.98–2.53) 0.062

2.29 (1.30–4.01) 0.004

0.93 (0.48–1.80) 0.834

Age-adjusted model

Referent

1.26 (0.78–2.04) 0.350

1.87 (1.06–3.30) 0.030

0.84 (0.44–1.62) 0.604

Waist circumference-adjusted model BP-adjusted model

Referent

1.32 (0.82–2.15) 0.256

1.86 (1.05–3.29) 0.034

0.93 (0.49–1.79) 0.834

TG-adjusted model

Referent

1.49 (0.92–2.41) 0.109

2.15 (1.21–3.81) 0.009

1.02 (0.53–1.96) 0.950

HDL-adjusted model

Referent

1.62 (1.00–2.61) 0.048

2.37 (1.35–4.18) 0.003

1.10 (0.57–2.10) 0.779

Waist circumference/BP/TG/

Referent

1.56 (0.97–2.52) 0.066

2.27 (1.29–4.00) 0.004

1.07 (0.56–2.04) 0.842

HDL- adjusted model

Referent

1.33 (0.81–2.17) 0.258

1.88 (1.05–3.35) 0.034

0.93 (0.48–1.80) 0.834

Models for the female population

Characteristics

Glucose Metabolism

(N = 7441)

Normal

EBG

T2D

IFG

No. of NVAF/No. of participants

38/5294

35/2147

14/873

21/1274

Univariable-adjusted model

Referent

2.29 (1.44–3.64) 0.001

2.25 (1.22–4.18) 0.010

2.32 (1.36–3.96) 0.002

Age-adjusted model

Referent

1.63 (1.02–2.61) 0.041

1.45 (0.78–2.71) 0.245

1.78 (1.03–3.06) 0.038

Waist circumference-adjusted model BP-adjusted model

Referent

1.97 (1.23–3.16) 0.005

1.88 (1.01–3.51) 0.048

2.04 (1.19–3.51) 0.010

TG-adjusted model

Referent

1.78 (1.11–2.85) 0.017

1.69 (0.90–3.16) 0.101

1.85 (1.07–3.18) 0.027

HDL-adjusted model

Referent

2.47 (1.54–3.95) 0.000

2.48 (1.32–4.66) 0.005

2.45 (1.43–4.22) 0.001

Waist circumference/BP/TG/

Referent

2.27 (1.43–3.62) 0.001

2.22 (1.19–4.14) 0.012

2.31 (1.35–3.95) 0.002

HDL- adjusted model

Referent

1.80 (1.12–2.91) 0.016

1.71 (0.90–3.23) 0.099

1.86 (1.08–3.22) 0.026

  1. ORs, 95%CIs, P-values were expressed in the model lines of the chart above. BP Blood Pressure, EBG Elevated Blood Glucose, HDL High-density Lipoprotein, NVAF Non-valvular Atrial Fibrillation, TG Triglycerides, T2D Type 2 Diabetes Mellitus